C-Mer Eye Care Holdings Ltd
HKEX:3309
Intrinsic Value
C-MER Eye Care Holdings Ltd. engages in the provision of treatments and therapy services for ophthalmic diseases. [ Read More ]
The intrinsic value of one
C-Mer Eye Care Holdings Ltd
stock under the Base Case scenario is
2.69
HKD.
Compared to the current market price of 2.82 HKD,
C-Mer Eye Care Holdings Ltd
is
Overvalued by 5%.
C-Mer Eye Care Holdings Ltd's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
C-Mer Eye Care Holdings Ltd or that its price is influenced by factors unrelated to fundamentals.
C-Mer Eye Care Holdings Ltd's market capitalization is 3.5B HKD.
C-Mer Eye Care Holdings Ltd stock price is 2.82 HKD.
C-Mer Eye Care Holdings Ltd stock (2.69 HKD) is 5% less than its price (2.82 HKD).
C-Mer Eye Care Holdings Ltd stock (2.32 HKD) is 18% less than its price (2.82 HKD). Open DCF Valuation
C-Mer Eye Care Holdings Ltd stock price (2.82 HKD) is 8% less than its Relative Value (3.06 HKD). Open Relative Valuation
C-Mer Eye Care Holdings Ltd has upside potential of 63% compared to the average analyst price target.
Open Wall St Estimates
C-Mer Eye Care Holdings Ltd's ROIC (Return on Invested Capital) has increased in the last 3 years from 2% to 4%.
C-Mer Eye Care Holdings Ltd's Revenue has grown by 11% over the past 12 months.
C-Mer Eye Care Holdings Ltd's ROE (Return on Equity) has increased in the last 3 years from -1% to 3%.
C-Mer Eye Care Holdings Ltd's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 4%.
C-Mer Eye Care Holdings Ltd's ROE (Return on Equity) for the past 12 months is very low and is equal to 3%.
C-Mer Eye Care Holdings Ltd has positive Operating Income for the last twelve months.
C-Mer Eye Care Holdings Ltd has positive Free Cash Flow for the last twelve months.
C-Mer Eye Care Holdings Ltd has positive Net Income for the last twelve months.
C-Mer Eye Care Holdings Ltd has positive Gross Profit for the last twelve months.
C-Mer Eye Care Holdings Ltd's short-term assets (720m HKD) exceed its short-term liabilties (389m HKD).
C-Mer Eye Care Holdings Ltd has a very low three-year average ROE (Return on Equity): 1%. The company is not efficient at transforming stockholders' equity into net income.
C-Mer Eye Care Holdings Ltd has a very low three-year average ROIC (Return on Invested Capital): 1%. The company is not efficient at using invested capital to generate operating income.
C-Mer Eye Care Holdings Ltd's Revenue has been growing by an exceptional 40% per year for the last 3 years.
C-Mer Eye Care Holdings Ltd has negative Net Debt. This means that the company has more cash and short-term investments (557m HKD) than debt (256m HKD).
C-Mer Eye Care Holdings Ltd generates enough operating income (134m HKD) to cover interest payments on its debt (19m HKD).
C-Mer Eye Care Holdings Ltd's long-term assets (3B HKD) exceed its long-term liabilties (903m HKD).
C-Mer Eye Care Holdings Ltd's D/E (Debt to Equity) is very low and is equal to 0.14.
C-Mer Eye Care Holdings Ltd's Altman Z-Score is very high and is equal to 4.51.
Valuation Backtest
C-Mer Eye Care Holdings Ltd
Run backtest to discover the historical profit from buying and selling
C-Mer Eye Care Holdings Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
C-Mer Eye Care Holdings Ltd
Balance Sheet Decomposition
C-Mer Eye Care Holdings Ltd
| Current Assets | 720.1m |
| Cash & Short-Term Investments | 557.4m |
| Receivables | 58.4m |
| Other Current Assets | 104.3m |
| Non-Current Assets | 2B |
| Long-Term Investments | 188.7m |
| PP&E | 992.8m |
| Intangibles | 802.2m |
| Other Non-Current Assets | 44.8m |
| Current Liabilities | 389.3m |
| Accounts Payable | 54.9m |
| Accrued Liabilities | 136.4m |
| Short-Term Debt | 9.3m |
| Other Current Liabilities | 188.7m |
| Non-Current Liabilities | 513.5m |
| Long-Term Debt | 246.5m |
| Other Non-Current Liabilities | 267m |
Earnings Waterfall
C-Mer Eye Care Holdings Ltd
|
Revenue
|
1.9B
HKD
|
|
Cost of Revenue
|
-1.3B
HKD
|
|
Gross Profit
|
619m
HKD
|
|
Operating Expenses
|
-484.9m
HKD
|
|
Operating Income
|
134.1m
HKD
|
|
Other Expenses
|
-72.1m
HKD
|
|
Net Income
|
62m
HKD
|
Free Cash Flow Analysis
C-Mer Eye Care Holdings Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
C-Mer Eye Care Holdings Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
C-Mer Eye Care Holdings Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
C-Mer Eye Care Holdings Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
C-Mer Eye Care Holdings Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
C-Mer Eye Care Holdings Ltd
According to Wall Street analysts, the average 1-year price target for
C-Mer Eye Care Holdings Ltd
is 4.59 HKD
with a low forecast of 4.55 HKD and a high forecast of 4.73 HKD.
Shareholder Return
Price
C-Mer Eye Care Holdings Ltd
| Average Annual Return | 2.64% |
| Standard Deviation of Annual Returns | 22.82% |
| Max Drawdown | -78% |
| Market Capitalization | 3.5B HKD |
| Shares Outstanding | 1 266 559 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
C-Mer Eye Care Holdings Ltd
Country
Industry
Market Cap
Dividend Yield
Description
C-MER Eye Care Holdings Ltd. engages in the provision of treatments and therapy services for ophthalmic diseases. The company employs 1,461 full-time employees The company went IPO on 2018-01-15. The ophthalmic services are surgeries for the treatment of cataract, glaucoma and strabismus, as well as eye diseases, including corneal and vitreoretinal diseases. The firm also sells vision aid products including glasses and lens, as well as pharmaceutical products. The firm's main subsidiaries are C-MER Eye Care Medical Group Limited and C-MER Eye Care Group Limited, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one
C-Mer Eye Care Holdings Ltd
stock under the Base Case scenario is
2.69
HKD.
Compared to the current market price of 2.82 HKD,
C-Mer Eye Care Holdings Ltd
is
Overvalued by 5%.
You don't have any saved screeners yet
